Inactive Instrument
Aradigm Corporation Share Price Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.89M 4.2M 3.96M 3.61M 6.76M 461M 6.78M 46.74M 18.14M 237M 18.34M 17.94M 762M | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.8M 11.01M 10.36M 9.47M 17.71M 1.21B 17.75M 122M 47.51M 620M 48.06M 47.01M 2B | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +36.88% | +25.50% | - | - | 702K | |
| -1.22% | -2.84% | -1.75% | +13.77% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +46.82% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.38% | -1.10% | +12.23% | +31.39% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | +2.96% | +0.53% | +73.84% | +110.13% | 30.55B | |
| Weighted average by Cap. | -0.81% | +0.11% | +89.33% | +128.84% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 195K 168K 158K 144K 270K 18.41M 271K 1.87M 724K 9.45M 732K 716K 30.43M | 14.46M 12.45M 11.71M 10.7M 20.01M 1.37B 20.07M 138M 53.7M 701M 54.32M 53.13M 2.26B |
| Net income | -32.94M -28.34M -26.67M -24.36M -45.57M -3.11B -45.69M -315M -122M -1.6B -124M -121M -5.14B | -10.7M -9.21M -8.67M -7.92M -14.81M -1.01B -14.85M -102M -39.74M -519M -40.2M -39.32M -1.67B |
| Net Debt | -9.37M -8.06M -7.59M -6.93M -12.97M -885M -13M -89.66M -34.79M -454M -35.19M -34.43M -1.46B | 7.91M 6.81M 6.41M 5.85M 10.95M 747M 10.98M 75.7M 29.38M 383M 29.71M 29.07M 1.23B |
Employees
-
